References

Abegaz TM, Tefera YG, Befekadu Abebe T. Target organ damage and the long term effect of nonadherence to clinical practice guidelines in patients with hypertension: a retrospective cohort study. Int J Hypertens. 2017; 2017 https://doi.org/10.1155/2017/2637051

Aronson JK. Compliance, concordance, adherence. Br J Clin Pharmacol.. 2007; 63:(4)383-384 https://doi.org/10.1111/j.1365-2125.2007.02893.x

Burns AD, Lane D, Cole R, Patel P, Gupta P. Cardiovascular medication stability in urine for non-adherence screening by LC-MS-MS. J Anal Toxicol.. 2019; 43:(4)325-329 https://doi.org/10.1093/jat/bky090

Calip GS, Elmore JG, Boudreau DM. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. Breast Cancer Res Treat.. 2017; 161:(1)161-172 https://doi.org/10.1007/s10549-016-4043-1

Cam MO, Baysan Arabaci L. Qualitative and quantitative steps on attitude scale construction. Turkish J Res Dev Nurs.. 2010; 259-271

Cramer JA, Roy A, Burrell A Medication compliance and persistence: terminology and definitions. Value Health. 2008; 11:(1)44-47 https://doi.org/10.1111/j.1524-4733.2007.00213.x

Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018; 8:(1) https://doi.org/10.1136/bmjopen-2017-016982

Hacihasanoğlu R, Gozum S. The effect of patient education and home monitoring on medication compliance, hypertension management, healthy lifestyle behaviours and BMI in a primary health care setting. J Clin Nurs.. 2011; 20:(5-6)692-705 https://doi.org/10.1111/j.1365-2702.2010.03534.x

Hill-McManus D, Marshall S, Soto E, Lane S, Hughes D. Impact of non-adherence and flare resolution on the cost-effectiveness of treatments for gout: application of a linked pharmacometric/pharmacoeconomic model. Value Health. 2018; 21:(12)1373-1381 https://doi.org/10.1016/j.jval.2018.06.002

Jank S, Bertsche T, Schellberg D, Herzog W, Haefeli WE. The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci.. 2009; 31:(4)426-431 https://doi.org/10.1007/s11096-009-9296-x

Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs.. 2000; 15:(3)90-96

Kim S, Shin DW, Yun JM Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016; 67:(3)506-512 https://doi.org/10.1161/hypertensionaha.115.06731

Kymes SM, Pierce RL, Girdish C Association among change in medical costs, level of comorbidity, and change in adherence behavior. Am J Manag Care. 2016; 22:(8)e295-301

Lloyd JT, Maresh S, Powers CA, Shrank WH, Alley DE. how much does medication nonadherence cost the medicare fee-for-service program?. Med Care. 2019; 57:(3)218-224 https://doi.org/10.1097/mlr.0000000000001067

Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24:(1)67-74 https://doi.org/10.1097/00005650-198601000-00007

Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10:(5)348-354

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med.. 2005; 353:(5)487-497 https://doi.org/10.1056/NEJMra050100

Park YH, Chang H, Kim J, Kwak JS. Patient-tailored self-management intervention for older adults with hypertension in a nursing home. J Clin Nurs.. 2013; 22:(5-6)710-722 https://doi.org/10.1111/j.1365-2702.2012.04236.x

Stavropoulou C. Perceived information needs and non-adherence: evidence from Greek patients with hypertension. Health Expect. 2012; 15:(2)187-196 https://doi.org/10.1111/j.1369-7625.2011.00679.x

Sung SF, Lai EC, Wu DP, Hsieh CY. Previously undiagnosed risk factors and medication nonadherence are prevalent in young adults with first-ever stroke. Pharmacoepidemiol Drug Saf.. 2017; 26:(12)1458-1464 https://doi.org/10.1002/pds.4250

Wild D, Grove A, Martin M Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (pro) measures: report of the ispor task force for translation and cultural adaptation. Value Health. 2005; 8:(2)94-104 https://doi.org/10.1111/j.1524-4733.2005.04054.x

Scales for assessing medication adherence in patients with hypertension

28 November 2019
9 min read
Volume 28 · Issue 21

Abstract

Background:

the choice of the appropriate tool for assessing level of medication adherence is a significant barrier in scientific research.

Aims:

to translate into Greek and test the reliability of the Hill-Bone and A-14 scales among patients with hypertension. Also, to compare patients' responses in the Hill-Bone scale, A-14 scale and Morisky Medication Adherence Scale (MMAS).

Methods:

data collection occurred between February 2016 and March 2016 at a general hospital in Athens, Greece. The sample consisted of hypertensive patients (n=34) and non-hypertensive patients (n=34).

Findings:

the coefficient alpha in hypertensive patients was 0.76 for Hill-Bone, 0.64 for MMAS and 0.91 for the A-14 scale. In non-hypertensive patients, the Cronbach's alpha for MMAS was 0.81 and 0.78 for A-14. A statistically significant difference was found among the mean scores of the scales, whereas strong correlation was found only between two pairs of questions with similar meaning.

Conclusion:

all tools are appropriate to assess the level of medication adherence in Greek hypertensive patients. However, careful translation of the scales is essential since items with the same meaning could be understudied in a different way.

Many terms are used to define the extent to which individuals take their medication as prescribed (Cramer et al, 2008). The most common of them are ‘adherence’ and ‘compliance’ (Osterberg and Blaschke, 2005; Aronson, 2007). Although the appropriate term has not been agreed, there is much research interest on the level of adherence to medication regimens, especially among patients with chronic diseases such as hypertension. The study of adherence is important since low levels of adherence are associated with high risks of mortality, deterioration in quality of life and increases in costs of health care (Cutler et al, 2018; Burns et al, 2019).

However, there are many tools for assessing the level of medication adherence and researchers must consider the validity and reliability of each scale to determine which is the most appropriate to be used in each study. In addition, researchers need to decide whether they want to use disease-specific or generic scales. For example, the Hill-Bone scale is a specific tool assessing adherence in treatment for hypertension (Kim et al, 2000), whereas the Morisky and A-14 scales are generic tools (Morisky et al, 1986; Jank et al, 2009). The choice of scale is further complicated by different tools using the same or similar questions.

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content